SMCs With LVH Compared to HCM

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

165 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-27

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this cohort study is to investigate the clinical characteristics of SMCs and to explore the difference in cardiovascular outcomes in comparison to age-, sex-, and admission year-matched HCM patients. The main question it aims to answer is:

* Do patients with SMCs have higher rates of cardiac outcomes?
* What risk factors do SMCs patients experience a poor prognosis?

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT06856265

Obstructive Hypertrophic Cardiomyopathy Mavacamten Radiofrequency Ablation

NOT_YET_RECRUITING NA

Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy

NCT06352307

Arrhythmogenic Cardiomyopathy

RECRUITING

IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure

NCT06866600

Heart Failure Heart Failure At NYHA Stage III or IV

NOT_YET_RECRUITING PHASE1/PHASE2

Residual or Recurrent Obstruction After Septal Myectomy

NCT05687487

Hypertrophic Obstructive Cardiomyopathy

COMPLETED

Transapical Beating-heart Septal Myectomy in Patient With Hypertrophic Obstructive Cardiomyopathy

NCT05332691

Hypertrophic Obstructive Cardiomyopathy

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Syndromic and Metabolic Cardiomyopathy Cardiomyopathies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMCs

patients with SMCs

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who were diagnosed SMCs or HCM. Gene testing and muscle biopsy were used to confirm the diagnosis of SMCs. The diagnose of HCM was according to the 2024 ESC Guidelines of HCM but without evidence of SMCs.
* complete baseline data
* accessible follow-up data